Luo Y - Search Results

1

The hydrophobic tunnel present in LOX-1 is essential for oxidized LDL recognition and binding.

Francone OL, Tu M, Royer LJ, Zhu J, Stevens K, Oleynek JJ, Lin Z, Shelley L, Sand T, Luo Y, Kane CD. Francone OL, et al. Among authors: luo y. J Lipid Res. 2009 Mar;50(3):546-555. doi: 10.1194/jlr.M800474-JLR200. Epub 2008 Oct 9. J Lipid Res. 2009. PMID: 18845619 Free article.

2

Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice.

Shelly L, Royer L, Sand T, Jensen H, Luo Y. Shelly L, et al. Among authors: luo y. J Lipid Res. 2008 Apr;49(4):773-81. doi: 10.1194/jlr.M700336-JLR200. Epub 2008 Jan 14. J Lipid Res. 2008. PMID: 18198166 Free article.

3

Function and distribution of circulating human PCSK9 expressed extrahepatically in transgenic mice.

Luo Y, Warren L, Xia D, Jensen H, Sand T, Petras S, Qin W, Miller KS, Hawkins J. Luo Y, et al. J Lipid Res. 2009 Aug;50(8):1581-8. doi: 10.1194/jlr.M800542-JLR200. Epub 2008 Dec 6. J Lipid Res. 2009. PMID: 19060325 Free PMC article.

4

Identification and characterization of dual inhibitors for phospholipid transfer protein and microsomal triglyceride transfer protein.

Luo Y, Shelly L, Sand T, Chang G, Jiang XC. Luo Y, et al. J Pharmacol Exp Ther. 2010 Dec;335(3):653-8. doi: 10.1124/jpet.110.171942. Epub 2010 Aug 30. J Pharmacol Exp Ther. 2010. PMID: 20805304 Free PMC article.

5

Pharmacologic inhibition of phospholipid transfer protein activity reduces apolipoprotein-B secretion from hepatocytes.

Luo Y, Shelly L, Sand T, Reidich B, Chang G, Macdougall M, Peakman MC, Jiang XC. Luo Y, et al. J Pharmacol Exp Ther. 2010 Mar;332(3):1100-6. doi: 10.1124/jpet.109.161232. Epub 2009 Nov 20. J Pharmacol Exp Ther. 2010. PMID: 19933370 Free PMC article.

6

Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435.

Bhat BG, Rapp SR, Beaudry JA, Napawan N, Butteiger DN, Hall KA, Null CL, Luo Y, Keller BT. Bhat BG, et al. Among authors: luo y. J Lipid Res. 2003 Sep;44(9):1614-21. doi: 10.1194/jlr.M200469-JLR200. Epub 2003 Jun 16. J Lipid Res. 2003. PMID: 12810816 Free article.

7

Chronic treatment with epoxyeicosatrienoic acids modulates insulin signaling and prevents insulin resistance in hepatocytes.

Skepner JE, Shelly LD, Ji C, Reidich B, Luo Y. Skepner JE, et al. Among authors: luo y. Prostaglandins Other Lipid Mediat. 2011 Feb;94(1-2):3-8. doi: 10.1016/j.prostaglandins.2010.10.002. Epub 2010 Oct 30. Prostaglandins Other Lipid Mediat. 2011. PMID: 21040800

8

Palmitate increases the susceptibility of cells to drug-induced toxicity: an in vitro method to identify drugs with potential contraindications in patients with metabolic disease.

Luo Y, Rana P, Will Y. Luo Y, et al. Toxicol Sci. 2012 Oct;129(2):346-62. doi: 10.1093/toxsci/kfs208. Epub 2012 Jun 14. Toxicol Sci. 2012. PMID: 22700542

9

Cyclosporine A and palmitic acid treatment synergistically induce cytotoxicity in HepG2 cells.

Luo Y, Rana P, Will Y. Luo Y, et al. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):172-80. doi: 10.1016/j.taap.2012.03.022. Epub 2012 Apr 6. Toxicol Appl Pharmacol. 2012. PMID: 22521608

10

Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump.

Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y. Aleo MD, et al. Among authors: luo y. Hepatology. 2014 Sep;60(3):1015-22. doi: 10.1002/hep.27206. Epub 2014 Jul 14. Hepatology. 2014. PMID: 24799086

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,950 results

Search Page

Filters